121 related articles for article (PubMed ID: 19919613)
1. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient.
Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH
Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
[TBL] [Abstract][Full Text] [Related]
3. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
[TBL] [Abstract][Full Text] [Related]
4. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
[TBL] [Abstract][Full Text] [Related]
7. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
8. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus for Kaposi's sarcoma.
Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Campistol JM; Schena FP
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
[TBL] [Abstract][Full Text] [Related]
11. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial MC; Iranzo P; Torregrosa JV; Oppenheimer F; Campistol JM
Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556
[TBL] [Abstract][Full Text] [Related]
13. Regression of post-transplant Kaposi's sarcoma using sirolimus.
Kolhe N; Mamode N; Van der Walt J; Pattison J
Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?
Rostaing L; Kamar N
J Nephrol; 2010; 23(2):133-42. PubMed ID: 20155724
[TBL] [Abstract][Full Text] [Related]
15. Kaposi sarcoma in solid organ transplant recipients: a single center report.
Boeckle E; Boesmueller C; Wiesmayr S; Mark W; Rieger M; Tabarelli D; Graziadei I; Hoefer D; Antretter H; Stelzmueller I; Krugmann J; Zangerle R; Huemer H; Poelzl G; Margreiter R; Bonatti H
Transplant Proc; 2005 May; 37(4):1905-9. PubMed ID: 15919500
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts.
Samaniego F; Young D; Grimes C; Prospero V; Christofidou-Solomidou M; DeLisser HM; Prakash O; Sahin AA; Wang S
Cell Growth Differ; 2002 Aug; 13(8):387-95. PubMed ID: 12193477
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity.
Haidinger M; Hecking M; Weichhart T; Poglitsch M; Enkner W; Vonbank K; Prayer D; Geusau A; Oberbauer R; Zlabinger GJ; Soleiman A; Hörl WH; Säemann MD
Transpl Int; 2010 Aug; 23(8):777-85. PubMed ID: 20070623
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
[TBL] [Abstract][Full Text] [Related]
20. Kaposi sarcoma in transplantation.
Lebbé C; Legendre C; Francès C
Transplant Rev (Orlando); 2008 Oct; 22(4):252-61. PubMed ID: 18656341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]